drug
valemetostat
Phase 2updated 5mo agoby Daiichi Sankyo Co Ltd
Phase 2community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying valemetostat
- phase1A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
- phase2A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
- phase1A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- phase1Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
- phase1A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- phase2Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
- phase2A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
- phase2A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that